Investment
Features
FeesSafety
Academy
More
Pluang+

'Rich Dad, Poor Dad' author linked to $1.2B real estate debt amid bullish Bitcoin price calls

Market News
01 Sep 2026
UToday
View Source
Neutral
pluang ai news

Robert Kiyosaki, author of 'Rich Dad Poor Dad' and a prominent Bitcoin advocate, is associated with $1.2 billion in debt tied to his real estate investments, though his personal share is estimated between $30 million and $60 million. Kiyosaki views debt as a tool for acquiring income-generating assets and continues to predict aggressive Bitcoin price targets, including $350,000 by 2025 and eventually over $1 million. This highlights his high-risk investment approach combining leveraged real estate holdings with bullish crypto bets.

More News

Dell beats revenue and earnings estimates, driven by AI server demand and $51B backlog.

Dell beats revenue and earnings estimates, driven by AI server demand and $51B backlog.

Dell Technologies reported quarterly revenue of $46.97 billion and earnings per share of $7.04, both surpassing analyst expectations. The company's growth is fueled by strong demand in its AI server business, supported by a substantial $51 billion or...

Company Fundamentals
Bullish
23 minutes ago
Medtronic raised to Buy with $100 target after strong Q1 revenue and $700M investment in Heart Tech.

Medtronic raised to Buy with $100 target after strong Q1 revenue and $700M investment in Heart Tech.

Analyst BTIG upgraded Medtronic to a Buy rating and raised its price target to $100, citing strong Q1 FY2027 revenue of $9.76 billion driven by broad demand. The company is investing over $700 million in Heart Tech and Robotics, signaling a focus on ...

Analyst Insights
Bullish
2 hours ago
Regis Corp beats Q4 2026 EPS estimates with $1.04, showing strong cash flow and stable revenue.

Regis Corp beats Q4 2026 EPS estimates with $1.04, showing strong cash flow and stable revenue.

Regis Corporation reported a strong Q4 2026 with earnings per share of $1.04, far exceeding analyst expectations of $0.17. The company generated $56 million in revenue, slightly down year-over-year but above estimates, supported by a 2.6% sales rise ...

Company Fundamentals
Bullish
2 hours ago
UBS keeps Buy on KKR with $123 target as KKR sells USI Insurance for $17B, boosting capital for new investments.

UBS keeps Buy on KKR with $123 target as KKR sells USI Insurance for $17B, boosting capital for new investments.

UBS analyst Michael Brown reaffirmed a Buy rating on KKR & Co. Inc., setting a $123 price target, implying a 15% upside. KKR is selling USI Insurance Services to Aon plc for $17 billion, expected to yield $3.3 billion in after-tax proceeds and $2 bil...

Analyst Insights
Bullish
3 hours ago
Kazia Therapeutics gains analyst confidence as its cancer drug shows strong preclinical results.

Kazia Therapeutics gains analyst confidence as its cancer drug shows strong preclinical results.

Kazia Therapeutics received a Buy rating from analyst firm BTIG, which raised its price target to $40, up from $34, reflecting strong confidence in the company's lead drug, paxalisib. The drug showed a 52% tumor reduction in preclinical colorectal ca...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App